There are 2789 resources available
79P - SETD2 a potential tissue-agnostic predictive biomarker for ICIs in solid tumors
Presenter: Yu Chen
Session: ePoster Display
80P - Blood tumor mutational burden (bTMB) and efficacy of immune checkpoint inhibitors (ICIs) in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN
Presenter: Mishima Saori
Session: ePoster Display
81P - Baseline circulating CD4+PD1+high T cells (TCD4PD1H) as predictors of survival in patients (P) with solid tumors treated with immune-checkpoint inhibitors (ICI)
Presenter: Javier Garcia-Corbacho
Session: ePoster Display
209P - Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
Presenter: Samuel Klempner
Session: ePoster Display
210P - TACH101, a first-in-class KDM4 inhibitor for treatment of triple-negative breast cancer
Presenter: Frank Perabo
Session: ePoster Display
211P - Genetic and immunologic characteristics in Chinese breast patients with different HER2 mutation types
Presenter: Hui Cao
Session: ePoster Display
212P - HER2-low breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatment
Presenter: Federica Miglietta
Session: ePoster Display
213P - Predictive markers of cardiotoxicity associated with breast cancer treatment
Presenter: Ines Nogueira Costa
Session: ePoster Display
214P - Landscape of homologous recombination repair gene mutations in different molecular subtypes of breast cancer
Presenter: Yan Xu
Session: ePoster Display
215P - Somatic mutations and gene expression of neuroendocrine pathways in aggressive and nonaggressive breast cancer
Presenter: Kejia Hu
Session: ePoster Display